Evidence map›Paper›PMID 41008871›Full record

ReviewCancers2025

Exploring the Oncogenic Potential of Human Papillomavirus in Subungual and Plantar Squamous Cell Carcinoma: A Review of the Literature.

Richard Moraga, Theresa Hopkins, Gracie S Sclamberg, Elisa S Gallo

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Richard MoragaRosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.ORCID 0009-0007-4607-0310
Theresa HopkinsRosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Gracie S SclambergSUNY Downstate Medical School, Brooklyn, NY 11203, USA.
Elisa S GalloRosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.ORCID 0000-0001-7109-2895

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSquamous cell carcinoma (SCC) of the nail unit, known as the subungual region, and of the plantar foot is rare but often misdiagnosed due to its similar appearance to verruca, a common wart. The delayed diagnosis and treatment of SCC in the subungual and plantar foot leads to poorer outcomes. Human papillomavirus (HPV), and specifically the oncogenic potential of particular strains, influences SCC pathogenesis, progression, and treatment response.

methodsThis review aims to address the current state of knowledge as well as deficits associated with clinical treatment of SCC in two anatomically challenging locations: verrucous carcinoma (VC), a variant of SCC that affects the plantar foot, and subungual SCC. Articles reviewed were evaluated based on date of publication, quality, and originality. Additionally, articles published after 2015 were given preferential consideration.

resultsThis review highlights considerations to reduce diagnostic delays and improve patient outcomes when considering two uncommon cutaneous malignancies.

conclusionsWe recognize that misdiagnosis poses a barrier in the treatment of both plantar VC and subungual SCC. As such, we identify pertinent clinical pearls to assist in accurate identification and treatment of SCC in these locations. Lastly, we address the role of HPV and the microbiome in the pathogenesis of SCC to improve treatment efficacy.

Indexed as

human papillomavirus (HPV)plantar verrucous carcinomasquamous cell carcinoma (SCC)subungual squamous cell carcinomaverruca plantarisverrucous carcinoma (VC)

Identifiers

PMID41008871
PMCPMC12468373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.